BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2016
View Archived Issues
Role of SUMOylated SOD2 in alcoholic liver disease and liver cancer
Read More
FDA expands indication for FluLaval influenza vaccine
Read More
FDA grants fast track designation to Oragenics' AG-013
Read More
IBT receives positive recommendation to continue phase II trial of IBP-9414
Read More
FDA lifts partial clinical hold on trials evaluating Aduro Biotech's LADD platform
Read More
AbbVie discontinues development program under Halozyme collaboration
Read More
Intarcia Therapeutics submits NDA for ITCA-650
Read More
Janssen Pharmaceutica patents TARPgamma8 inhibitors
Read More
WHO announces global health funding for RTS,S malaria vaccine
Read More
Janssen R&D Ireland discloses agents for RSV infection
Read More
Actelion Pharmaceuticals describes TPHI1 inhibitors
Read More
Rosetta Genomics enters research agreement with Sheba Medical Center
Read More
FDA approves Darzalex in combination with standard of care for relapsed multiple myeloma
Read More
Roche presents HBsAg and HBV DNA production inhibitors
Read More
FDA approves Soliqua for type 2 diabetes
Read More
FDA lifts partial clinical hold on head and neck cancer trials of durvalumab
Read More
Midatech receives payment under Emergex license contract
Read More
Pan-Nox inhibitor for diabetic nephropathy
Read More
Novo Nordisk's Xultophy wins FDA approval for type 2 diabetes
Read More
Sandoz's epoetin alfa biosimilar for renal anemia
Read More
Regulus chemically modified oligonucleotide for Alport syndrome
Read More
Novel Zika virus vaccine based on the Zika E glycoprotein
Read More
Phase I clinical testing of the hookworm vaccine NA-APR-1
Read More
License and collaboration between Arrowhead and Amgen closed
Read More
Spectrum Pharmaceuticals receives CRL from FDA on Qapzola
Read More